GCM
PFE icon

Gladius Capital Management’s Pfizer PFE Stock Holding History

Gladius Capital Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-1,043
Closed -$30.2K – 207
2024
Q3 		$30.2K Sell
1,043
-35,585
-97% -$1.04M ﹤0.01% 226
2024
Q2 		$1.02M Buy
36,628
+31,506
+615% +$867K 0.13% 78
2024
Q1 		$142K Buy
5,122
+3,515
+219% +$97.5K 0.05% 136
2023
Q4 		$46.3K Sell
1,607
-92,174
-98% -$2.79M 0.01% 184
2023
Q3 		$3.11M Buy
93,781
+67,349
+255% +$2.38M 0.13% 104
2023
Q2 		$970K Sell
26,432
-18,242
-41% -$710K 0.05% 98
2023
Q1 		$1.82M Buy
44,674
+35,972
+413% +$1.55M 0.11% 88
2022
Q4 		$446K Sell
8,702
-61,936
-88% -$2.97M 0.03% 104
2022
Q3 		$3.09M Buy
70,638
+69,663
+7,145% +$3.39M 0.14% 67
2022
Q2 		$52K Sell
975
-6,472
-87% -$330K ﹤0.01% 252
2022
Q1 		$386K Buy
7,447
+476
+7% +$24.7K 0.03% 120
2021
Q4 		$412K Buy
6,971
+6,452
+1,243% +$320K 0.03% 125
2021
Q3 		$23K Sell
519
-2,300
-82% -$102K ﹤0.01% 114
2021
Q2 		$111K Sell
2,819
-6,223
-69% -$242K 0.01% 111
2021
Q1 		$328K Buy
+9,042
New +$321K 0.01% 155
2020
Q4 		– Sell
-5,364
Closed -$197K – 185
2020
Q3 		$187K Buy
+5,364
New +$188K 0.02% 166
2020
Q1 		– Sell
-36,656
Closed -$1.36M – 171
2019
Q4 		$1.36M Buy
+36,656
New +$1.31M 0.09% 119
2019
Q3 		– Sell
-7,863
Closed -$286K – 217
2019
Q2 		$327K Sell
7,863
-97,199
-93% -$3.86M 0.02% 149
2019
Q1 		$4.23M Sell
105,062
-72,237
-41% -$2.89M 0.23% 63
2018
Q4 		$7.34M Buy
177,299
+170,537
+2,522% +$7.08M 0.36% 58
2018
Q3 		$283K Sell
6,762
-15,631
-70% -$602K 0.03% 66
2018
Q2 		$771 Buy
+22,393
New +$765K 0.08% 58

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Gladius Capital Management's PFE Position: Q4 2024 in Review

Gladius Capital Management sold out of Pfizer (PFE) in Q4 2024, closing a stake of 1,043 shares — an estimated $30.2K sold.

Gladius Capital Management first reported a position in PFE in Q2 2018 and held it in 22 quarters. The position peaked at $7.34M in Q4 2018. 2,995 funds tracked by Wall St. Rank hold PFE as of Q4 2024.

  • Gladius Capital Management reported no remaining Pfizer position as of Q4 2024 after selling out during the quarter.
  • Gladius Capital Management sold 1,043 Pfizer shares in Q4 2024, an estimated $30.2K.
  • Gladius Capital Management first reported a position in Pfizer in Q2 2018 and held it in 22 quarters.
  • Gladius Capital Management's Pfizer position peaked at $7.34M in Q4 2018.
  • 2,995 funds tracked by Wall St. Rank held Pfizer as of Q4 2024.

Based on Gladius Capital Management's 13F filing for Q4 2024, filed 31 Jan 2025.